Financials
| Trading and Funding Update | Jun. 10, 2024 |
| Final results for 2023 | May. 16, 2024 |
| Year End Trading Update | Feb. 01, 2024 |
| Interim Results for six months ended 30 June 2023 | Sep. 14, 2023 |
| ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM | May. 04, 2023 |
| Interim Results for six months ended 30 June 2022 | Sep. 08, 2022 |
| FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021 | Apr. 25, 2022 |
Proxies
| Result of AGM | Jun. 28, 2024 |
| Posting of 2023 Annual Report and Notice of AGM | May. 31, 2024 |
| Result of AGM | Jun. 09, 2023 |
| AGM Statement | Jun. 09, 2023 |
| RESULT OF AGM | May. 23, 2022 |
| Arecor AGM statement | May. 23, 2022 |
Ownership Update
| Grant of Options and PDMR Dealing | May. 23, 2024 |
| Director/PDMR Shareholding | May. 24, 2023 |
| Grant of LTIP Options and PDMR Dealing | Dec. 06, 2022 |
| Exercise of options and PDMR dealing | Nov. 08, 2022 |
| Holding(s) in Company | Aug. 05, 2022 |
| Holding(s) in Company | Aug. 05, 2022 |
| Holding(s) in Company | Aug. 04, 2022 |
Announcements
| Posting of Circular and General Meeting | Jul. 23, 2024 |
| Result of WRAP Retail Offer | Jul. 23, 2024 |
| Result of Placing and Subscription | Jul. 19, 2024 |
| WRAP Retail Offer to raise up to £1 million | Jul. 19, 2024 |
| Proposed Placing and Subscription | Jul. 19, 2024 |
| Arecor to host company and KOL webinar today | May. 21, 2024 |
| Positive headline results for AT278 clinical trial | May. 20, 2024 |